Wordt geladen...
Cost Effectiveness of Voretigene Neparvovec for RPE65-Mediated Inherited Retinal Degeneration in Germany
PURPOSE: Voretigene Neparvovec-rzyl (VN) is the first available treatment for biallelic RPE65 mutation-associated inherited retinal degeneration, which is usually associated with infancy-onset severe visual impairment and complete blindness during the third life decade. We aim to estimate the cost e...
Bewaard in:
| Gepubliceerd in: | Transl Vis Sci Technol |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
The Association for Research in Vision and Ophthalmology
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7442871/ https://ncbi.nlm.nih.gov/pubmed/32879773 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1167/tvst.9.9.17 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|